Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

Recently, we have shown that metastasis-free survival is a strong surrogate for overall survival (OS) in men with intermediate- and high-risk localized prostate cancer and can accelerate the evaluation of new (neo)adjuvant therapies. Event-free survival (EFS), an earlier prostate-specific antigen (P...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:J Clin Oncol
المؤلفون الرئيسيون: Xie, Wanling, Regan, Meredith M., Buyse, Marc, Halabi, Susan, Kantoff, Philip W., Sartor, Oliver, Soule, Howard, Berry, Donald, Clarke, Noel, Collette, Laurence, D’Amico, Anthony, Lourenco, Richard De Abreu, Dignam, James, Eisenberger, Mario, James, Nicholas, Fizazi, Karim, Gillessen, Silke, Loriot, Yohann, Mottet, Nicolas, Parulekar, Wendy, Sandler, Howard, Spratt, Daniel E., Sydes, Matthew R., Tombal, Bertrand, Williams, Scott, Sweeney, Christopher J.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society of Clinical Oncology 2020
الموضوعات:
ORIGINAL REPORTS
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265328/
https://ncbi.nlm.nih.gov/pubmed/32552276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.03114
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة